Phase Three Clinical Trials for Lyme Vaccine in NY

Clinical Trials for Lyme VaccineSpectrum News 1 journalist, Viktoria Hallikäär, 01.03.2024, reports “N.Y. Lyme disease study aims to get preventative vaccine approved.” The Valneva/Pfizer Lyme vaccine candidate is in phase three study across many places in Pennsylvania (PA) and New York (NY). Guthrie, NY is one of the locations where vaccine testing is ongoing with trial participants ranging from ages 9 to 90. Testing began in 2002 and will end in 2025, with potential for a new Lyme disease vaccine to be on the market by 2026.

For More Information: 

Read/View Spectrum News 1 News Piece

More LDA Articles on Lyme Vaccine